Catch up on what happened in optometry during the week of January 15-January 19.
Catch up with what Optometry Times shared this week:
By Jacqueline Theis, OD, FAAO
New developments to progress diagnostic criteria for Mild Traumatic Brain Injury (TBI) are discussed by The Mild Traumatic Brain Injury (TBI) Task Force of the American Congress of Rehabilitation Medicine Brain Injury Special Interest Group.
By Jordana Joy, Associate Editor
The European companies are collaborating in part of a strategic distribution partnership before the eProgressive smart glasses are available to the public later this year. The smart glasses use switchable lens technology to provide ease and comfort to patients needing progressive lenses.
By Danica Marrelli, OD, FAAO; Emily Kaiser Maharjan, Assistant Managing Editor; Jordana Joy, Associate Editor
Danica Marrelli, OD, FAAO, AAO Dipl, sat down with Optometry Times to chat about the upcoming EnVision Summit 2024, which is set to take place February 16-19 in Puerto Rico. This year, the meeting includes an Optometry Program, which is chaired by Marrelli and Cecelia Koetting, OD, FAAO, DipABO. Marrelli discusses what optometrists can expect from the family-oriented meeting, from exciting geographic atrophy and glaucoma co-managment panels to a built-in kids track to keep loved ones engaged during CE sessions.
By Lynda Charters
A collaborative study has found that pupillometry as a clinical test may help identify biomarkers for major depressive disorder. The test identifies a subgroup of patients with anticipatory hypo-arousal subserving anhedonia symptomatology.
By Robert Weiss, BS; Emily Kaiser Maharjan, Assistant Managing Editor; Jordana Joy, Associate Editor
Robert Weiss, former president and CEO of The Cooper Companies, shares some of the latest optometric schooling developments from Vietnam in his work with Optometry Giving Sight, the Brian Holden Foundation, and Hanoi Medical University.